{
    "title": "Covid-19 antibody treatment trial to move on to next phase",
    "url": "https://www.dailymail.co.uk/wires/pa/article-8810417/Covid-19-antibody-treatment-trial-to-phase.html",
    "date": "2020-10-06",
    "keywords": [
        "antibody",
        "vir7831",
        "infection",
        "gsk",
        "vir",
        "trial",
        "coronavirus",
        "treatment",
        "study",
        "covid19",
        "virus",
        "barrier",
        "america",
        "officer",
        "fight",
        "phase",
        "president",
        "trump",
        "drug",
        "body",
        "glaxosmithkline",
        "biotechnology",
        "cometice",
        "efficacy",
        "trialintent",
        "risk",
        "gsk4182136",
        "ability",
        "resistance",
        "south",
        "europe",
        "george",
        "achievement",
        "milestone",
        "urgency",
        "hope",
        "sample",
        "scientist",
        "whilst",
        "lighthouse",
        "laboratory",
        "elizabeth",
        "university",
        "hospital",
        "glasgow",
        "scotland",
        "plan",
        "andrew",
        "milliganpa",
        "hospitalisation",
        "death",
        "development",
        "dr",
        "hal",
        "barron",
        "chief",
        "research",
        "design",
        "patient",
        "need",
        "collaboration",
        "effector",
        "function",
        "delivery",
        "lung",
        "end",
        "spotlight",
        "regeneron",
        "company",
        "dose",
        "request",
        "physician",
        "compassionate",
        "use",
        "latestage",
        "testing",
        "safety",
        "effectiveness",
        "illness",
        "occurs",
        "vaccine"
    ],
    "category": [
        "wires",
        "pa"
    ]
}